ARCHIVES

NCAB May Make Its Recommendation On Comprehensive Center Issues At September Meeting

This article is from The Cancer Letter archive.

Vol. 14 No. 32 | August 5, 1988

Download PDF Visit The Full Archive

Related Articles

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

AACI Leaders Regret “Unfortunate Rhetoric,” Pledge Support To Broder

August 11, 1989

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

Act To Get Only One-Year Extension Now NCAB; ACCC, ACI Adopt Recommendations For changes

February 4, 1977

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010